Details of the Drug
General Information of Drug (ID: DMC10HG)
| Drug Name |
5-methyl-2-(phenylsulfonamido)benzoic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
5-Methyl-2-[(phenylsulfonyl)amino]benzoic acid; 5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID; 2-benzenesulfonamido-5-methylbenzoic acid; A41; 1yw7; sulfonamide compound, 4; AC1O0UU4; SCHEMBL2009251; CHEMBL378927; Anthranilic Acid Sulfonamide, 4; BDBM17477; MolPort-004-356-849; HMS3604F08; STK978137; ZINC14964411; AKOS000202786; MCULE-6409447208; DB07313; 138964-56-4; 2-(benzenesulfonamido)-5-methylbenzoic acid; A444148
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 291.32 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.9 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


